Skip to main content
Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.630
-0.020 (-1.21%)
At close: Apr 28, 2026, 4:00 PM EDT
1.570
-0.060 (-3.68%)
After-hours: Apr 28, 2026, 7:48 PM EDT

Co-Diagnostics Revenue

In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%. Co-Diagnostics had revenue of $263.92K in the quarter ending December 31, 2025, with 76.74% growth.

Revenue (ttm)
$622.49K
Revenue Growth
-84.10%
P/S Ratio
9.20
Revenue / Employee
$5,413
Employees
115
Market Cap
5.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025622.49K-3.29M-84.10%
Dec 31, 20243.92M-2.90M-42.53%
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Beyond Air 6.92M
Biomerica 4.33M
Tenon Medical 3.94M
Intelligent Bio Solutions 3.58M
Sintx Technologies 1.02M
iTonic Holdings 523.03K
Tivic Health Systems 482.00K
Nexalin Technology 301.65K
Revenue Rankings

CODX News

More News